國家衛生研究院 NHRI:Item 3990099045/10373
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12189/12972 (94%)
造访人次 : 955518      在线人数 : 740
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10373


    题名: Verapamil use is associated with reduction of newly diagnosed diabetes mellitus
    作者: Yin, T;Kuo, SC;Chang, YY;Chen, YT;Wang, KK
    贡献者: Division of Infectious Diseases
    摘要: Objective: The mechanism of the beneficial effect of calcium channel blockers (CCBs), especially verapamil, on the development of type 2 diabetes mellitus (T2DM) has been described. Previous clinical studies aiming to confirm these results were flawed by inappropriate comparator drugs or study designs. This study compared the incidence of T2DM in adults prescribed oral verapamil and propensity score-matched adults prescribed other oral CCBs. Methods: This retrospective population-based cohort study used Taiwan's National Health Insurance Research Database during 2000-2011. T2DM was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification. Results: During follow-up periods of 41,958 and 42,118 person-years, 269/4930 patients in the verapamil cohort and 340/4930 patients in the matched cohort, respectively, developed T2DM. The incidence rates were 6.41 and 8.07 per 1000 population per year among verapamil and other CCB users, respectively. The adjusted hazard ratio (HR) for T2DM associated with use of verapamil (vs. other CCBs) was 0.80 (95% confidence interval [CI], 0.68-0.94; P = 0.006). After excluding those followed for <180 or <365 days to avoid bias derived from delayed diagnosis, adjusted HRs remained significant (0.79, 95% CI, 0.67-0.93, P = 0.005 and 0.77, 95% CI, 0.65-0.91, P = 0.002, respectively). Only the interaction term for age was significant (P = 0.009). Verapamil had a more prominent effect on those aged > 65 years (P< 0.001). Conclusions: In patients with no known history of DM, oral verapamil use was associated with a decreased incidence of T2DM compared with other CCBs.
    日期: 2017-07
    關聯: Journal of Clinical Endocrinology and Metabolism. 2017 Jul;102(7):2604-2610.
    Link to: http://dx.doi.org/10.1210/jc.2016-3778
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0021-972X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000405621600058
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85023199809
    显示于类别:[郭書辰] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB28368479.pdf185KbAdobe PDF172检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈